Hypoaldosteronism risk factors

Jump to navigation Jump to search

Hypoaldosteronism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypoaldosteronism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypoaldosteronism risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypoaldosteronism risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypoaldosteronism risk factors

CDC on Hypoaldosteronism risk factors

Hypoaldosteronism risk factors in the news

Blogs on Hypoaldosteronism risk factors

Directions to Hospitals Treating Hypoaldosteronism

Risk calculators and risk factors for Hypoaldosteronism risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]

Overview

Common risk factors in the development of hypoaldosteronism include diabetes mellitus, sickle cell anemia, HIV, graves' disease, hypoparathyroidism, hypopituitarism, myasthenia gravis, and pernicious anemia. Other less common risk factors include multiple myeloma, SLE-associated renal disease and Wolmans disease.

Risk Factors

Common risk factors in the development of hypoaldosteronism include:[1][2][3]

Less Common Risk Factors

Less common risk factors in the development of hypoaldosteronism include:[4][5]

References

  1. Uribarri J, Oh MS, Carroll HJ (1990). "Hyperkalemia in diabetes mellitus". J Diabet Complications. 4 (1): 3–7. PMID 2141843.
  2. Bojestig M, Nystrom FH, Arnqvist HJ, Ludvigsson J, Karlberg BE (2000). "The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes". J Renin Angiotensin Aldosterone Syst. 1 (4): 353–6. doi:10.3317/jraas.2000.065. PMID 11967822.
  3. Michels AW, Eisenbarth GS (2010). "Immunologic endocrine disorders". J. Allergy Clin. Immunol. 125 (2 Suppl 2): S226–37. doi:10.1016/j.jaci.2009.09.053. PMC 2835296. PMID 20176260.
  4. Shaked Y, Blau A, Shpilberg O, Samra Y (1993). "Hyporeninemic hypoaldosteronism associated with multiple myeloma: 11 years of follow-up". Clin. Nephrol. 40 (2): 79–82. PMID 8222376.
  5. Porteous, Haldane; Morgan, Nadia; Lanfranco, Julio; Garcia-Buitrago, Monica; Young, Larry; Lenz, Oliver (2011). "Systemic lupus erythematosus associated with type 4 renal tubular acidosis: a case report and review of the literature". Journal of Medical Case Reports. 5 (1). doi:10.1186/1752-1947-5-114. ISSN 1752-1947.

Template:WH Template:WS